GenesisCare

bankrupt

Healthcare — KKR

Deal Terms

Entry Year2019

Entry EV$5B

Entry Multiple12x

Leverage6x

Debt Amount$3B

Outcome

Exit Year2023

Risk Metrics

LTV (est.)60%

Debt / EV0.60x

Notes

Australia-based oncology/cardiology provider. KKR invested $2B+. Filed Chapter 11 in June 2023. Rapid expansion into US market proved disastrous. COVID volume declines + high debt + integration failures. US operations sold for pennies on the dollar.

Sponsor

KKR & Co.$638B AUM